July, 7, 2020
Santen Pharmaceutical Co., Ltd. (hereinafter, “Santen”) is working to advance ophthalmology and improve Quality of Vision (QOV) and Quality of Life (QOL) of people around the world, taking a thorough customer-oriented approach and harnessing our expertise and technical capabilities under the CORE PRINCIPLE of “Tenki ni Sanyo suru”
We believe that taking on the challenge of resolving social issues related to the eye health of people around the world and contributing to improved eye health is our mission as a specialized company dedicated to ophthalmology.
Due to the COVID-19 pandemic, which has spread around the world, we must examine potential new lifestyles, new ways of organizing society, and the roles companies should play within these social frameworks. As we celebrate the 130th anniversary of the company this year, we strive to continue serving as a force playing an indispensable role in the resolution of worldwide social issues related to eye health. With this goal in mind, we have drawn up a new long-term vision that will take the company forward to 2030 and beyond.
New Long-Term Vision
The Background to Our Long-Term Vision
Currently at least 2.2 billion people around the world live with visual impairments or blindness, and more than one billion of these people are either untreated or could have benefited from effective treatment2 . In the coming years, factors including economic growth in various nations as well as growing populations and increasing numbers of senior citizens around the world, particularly in Asia, are expected to increase the number of patients with eye conditions resulting from advanced age and lifestyle-related diseases. Furthermore, the influence of COVID-19 is already resulting in the wider use of IT-based tools to communicate, and as a result the number of people living with eye problems caused by long hours using digital devices, including eye fatigue and short-sightedness, is also expected to increase.
Meanwhile, in the field of life sciences, major changes are predicted to take place in the coming 10 to 20 years. These include services that are more finely-tailored to individuals, and increased level of interest in health and wellness among the general public, technical advances such as AI, IoT and automation, and further developments in the fields of cellular, genetic and digital device technology. These factors will require new solutions for issues related to eye health. We have formulated this long-term vision with these environmental changes in mind, and with consideration for how we as a company should address these global social issues.
(Santen Pharmaceutical Co., Ltd. (Headquartered in Osaka City) As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan and its products now reach patients in over 60 countries. With scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the wellbeing of patients, their loved ones and consequently to society. For more information, please visit Santen’s website (www.santen.com).
We are inviting Individual Blogger | News Publications | Professionals | Brands | Citizens | Kids | Youth | Social Workers to
Contact/WhatsApp: +91 7827887720 Email: firstname.lastname@example.org
Disclaimer: The perspectives communicated in the article/news/press release above are those of the writers’ and don’t really speak to or mirror the perspectives of this website or its personnel. Except if in any case noticed, the writer is writing in his/her own ability. They are not expected and ought not to be thought to speak to legitimate thoughts, perspectives, or strategies of any individual, Institution, organization or foundation.